A blog about the Life, the Universe and everything else :).
Online services that match patients to ongoing personalized drug trials based on the molecular characteristics of their disease may bias drug/diagnostic co-development studies and make the treatment and test appear more efficacious than they actually are, a US Food and Drug Administration bio-statistics expert recently cautioned
